)
Visual24 Oct 2025
The rise of Alphabet
Abbott Laboratories (ABT) investor relations material
Abbott Laboratories Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary15 Oct, 2025
Executive summary
Q3 2025 worldwide sales reached $11.4 billion, up 6.9% year-over-year, with 7.5% organic growth excluding COVID-19 testing, led by double-digit growth in Medical Devices and strong performance in Established Pharmaceuticals and key international markets.
Adjusted diluted EPS was $1.30, up 7.4% year-over-year, while GAAP diluted EPS was $0.94; net earnings for Q3 were $1.64 billion.
Recently launched products contributed nearly $500 million in sales and added over 100 basis points to organic growth.
Regulatory milestones included approvals for TriClip in Japan, expanded Navitor TAVI indication in Europe, and CE Mark for Volt PFA System.
The company remains confident in sustaining high single-digit organic sales growth and double-digit EPS growth into 2026, supported by innovation, a robust pipeline, and reaffirmed full-year guidance.
Financial highlights
Q3 2025 net sales were $11.4 billion, up 6.9% year-over-year, with organic sales growth of 7.5% excluding COVID-19 testing.
Adjusted gross margin was 55.8% of sales, with year-to-date gross margin at 52.4%, reflecting improvement initiatives and some tariff impact.
Adjusted operating margin was 23%, up 40 basis points year-over-year; GAAP operating margin was 18.1%.
Operating earnings for Q3 were $2.06 billion, up from $1.86 billion in Q3 2024.
Foreign exchange had a favorable 1.4% impact on Q3 sales.
Outlook and guidance
Reaffirmed full-year 2025 organic sales growth guidance of 7.5%–8.0% (excluding COVID-19 testing), and adjusted diluted EPS guidance of $5.12–$5.18, reflecting double-digit growth at the midpoint.
Confident in delivering high single-digit organic sales growth and double-digit EPS growth for 2025 and 2026, supported by new product launches and easing diagnostics headwinds.
Gross margin expansion expected to continue, targeting a 57% profile.
Foreign exchange expected to have a 1.5% favorable impact on Q4 sales.
COVID-19 testing sales expected to remain low, with Diagnostics facing continued headwinds in China.
AVEIR: Dual chamber penetration drivers?
Diagnostics ex-China growth drivers?
M&A: Strategic focus areas?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Abbott Laboratories earnings date
Q4 202521 Jan, 2026
Next Abbott Laboratories earnings date
Q4 202521 Jan, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
The Business of Life
Abbott Laboratories is an American global and multinational healthcare company headquartered in Chicago, Illinois, and listed on the NYSE. The company is focused on manufacturing various medical devices and medications. Its products include diagnostics equipment, medical devices, nutritionals, and branded generic pharmaceuticals. Some of Abotts more well-known products include Pedialyte and FreeStyle, the latter being a monitoring system for people living with diabetes.
Sprung from a small Pharmacy
The inception of Abbott Laboratories can be traced back to 1888 when Dr. Wallace C. Abbott founded it in Chicago. Initially operating as a small pharmacy, Dr. Abbott's business focused on creating standardized drug dosages, known as "dosimetric granules", of commonly used medications. Over the decades, the company underwent significant expansion in terms of its product range and geographical outreach, transforming from its humble beginnings into a notable player in the global pharmaceutical industry.
What They Do
Abbott Laboratories offers a wide array of products and services within healthcare and nutrition. In diagnostics, it supplies tools and tests to medical facilities used in the identification of different illnesses. The company's medical devices segment manufactures equipment used in areas like cardiology, diabetes care, and neuromodulation. Additionally, they also manufacture and sell branded generic pharmaceuticals that can be purchased over the counter at pharmacies like CVS. Their portfolio of nutritional products includes products aimed both at infants and small kids, as well as adults.
Abbott Laboratories and AbbVie
In 2013, Abbott Laboratories underwent a significant transformation by spinning off its research-based pharmaceuticals division into a separate company: AbbVie. This strategic decision was aimed at allowing both companies to focus more distinctly on their respective sectors. While Abbott Laboratories retained its portfolio including medical devices, diagnostics, and nutrition, AbbVie took over the responsibility for the research-driven pharmaceutical business. This split allowed Abbott to concentrate on its extensive range of products and services, whereas AbbVie could focus on the development and commercialization of advanced therapies.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage